Answers are grounded in this paper and cite their sources.
Diabetes mellitus is a major public health problem associated with serious long-term complications. Glycohemoglobin, a reliable index of the average blood glucose level during the previous 2 to 3 months, is now used routinely to monitor glycemic control in diabetic individuals. The assays most commonly used to measure glycohemoglobin levels include ion-exchange chromatography, electrophoresis, and affinity chromatography. Not all methods measure the same glycohemoglobin component, however; assay results depend on the component measured and the assay used. The need for standardization of glycohemoglobin values between laboratories has been recognized, but not yet implemented. Glycated serum protein and glycoalbumin measurements, which provide an index of glycemia over a 2- to 4-week period, have been investigated as alternatives for monitoring glycemic control. Methods to determine levels of these components in patients include nitroblue tetrazolium reduction and affinity chromatography. However, the value of these methods for monitoring glycemic control over a shorter period is still in question. Glycated protein measurements have been studied for their use in diabetes screening. Further studies are needed, however, to determine whether these measurements are sensitive enough to identify most individuals at risk for diabetic complications.
No takes yet. Share an insight, caveat, or question.
Little et al. (1992) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: